3646 results for «574»
3646 results
Featured Research - Tricuspid valve (Part 3)
25 Nov 2024 – From PCR London Valves 2024
Dive into the latest advancements in tricuspid valve interventions in this featured research session. Explore the systematic review of novel balloon-expandable valves across different cardiac locations, the impact of transcatheter tricuspid valve repair on patient health status, and the value of the pulmonary artery pulsatility index...
Featured Cases - Challenging Mitral TEER (Part 1)
25 Nov 2024 – From PCR London Valves 2024
Dive into a collection of challenging mitral transcatheter edge-to-edge repair (M-TEER) cases in this featured session. Explore strategies for coapting the non-regurgitant A2P2 segment in functional mitral regurgitation, the use of 4D-volume intracardiac echocardiography-only guidance, and the application of the diamond-shape clasping technique using the PASCAL...
Featured Research - Tricuspid valve (Part 4)
25 Nov 2024 – From PCR London Valves 2024
Dive deeper into the latest research on transcatheter tricuspid valve interventions in this featured session. Explore the clinical impact of vena contracta area planimetry in secondary tricuspid regurgitation, the significance of tricuspid valve anatomy in transcatheter tricuspid edge-to-edge repair (T-TEER), and the implications of tricuspid right...
Featured Cases - Challenging mitral TEER (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Explore a collection of challenging mitral transcatheter edge-to-edge repair (M-TEER) cases in this featured session. Gain insights into managing severe mitral regurgitation in an octogenarian with Barlow's syndrome, tackling the A1 prolapse, performing TEER for mitral valve prolapse at the commissure, and addressing severe mitral regurgitation...
TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation
31 Mar 2026
Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.
Author
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
